Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript
05:30pm, Tuesday, 12'th May 2020
Joining me on the call today is Dr. Thomas Schall, President and Chief Executive Officer of ChemoCentryx, who will review the company's recent business and clinical progress. Following his comments,
Biotech's Golden Moment As Healthcare Attracts Investors
01:31pm, Tuesday, 12'th May 2020
Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process. Healthcare has attrac
Edited Transcript of CCXI earnings conference call or presentation 11-May-20 9:00pm GMT
01:30pm, Tuesday, 12'th May 2020
Q1 2020 ChemoCentryx Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates
11:55pm, Monday, 11'th May 2020
ChemoCentryx (CCXI) delivered earnings and revenue surprises of -16.67% and -32.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ChemoCentryx Reports First Quarter 2020 Financial Results and Recent Highlights
08:05pm, Monday, 11'th May 2020
ChemoCentryx, Inc., (CCXI), today announced financial results for the first quarter ended March 31, 2020 and provided an overview of the Company's recent corporate highlights. "In the face of this
Is There An Opportunity With ChemoCentryx, Inc.'s (NASDAQ:CCXI) 47% Undervaluation?
11:00am, Monday, 11'th May 2020
Today we will run through one way of estimating the intrinsic value of ChemoCentryx, Inc. (NASDAQ:CCXI) by estimating...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
ChemoCentryx to Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020
12:30pm, Monday, 04'th May 2020
ChemoCentryx, Inc., (CCXI), today announced that the Company's first quarter 2020 financial results will be released after market close on Monday, May 11, 2020. ChemoCentryx executive management wi
